Meningococcal Serogroup C Conjugate Vaccination in Canada: How Far Have We Progressed? How Far Do We Have to Go?

National Advisory Committee on Immunization (NACI). Enhanced Surveillance of Invasive Meningococcal Disease in Canada: 1 January, 2004, through 31 December, 2005. Can Commun Dis Rep 2007;33(10):1–15.

National Advisory Committee on Immunization (NACI). Update on the Invasive Meningococcal Disease and Meningococcal Vaccine Conjugate Recommendations. Can Commun Dis Rep 2009;36(ACS3):1-40.

Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: Database analysis. BMJ 2003;326(7385):365–66.

Miller E, Salisbury D, Ramsay M. Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: A success story. Vaccine 2001;20(Suppl 1):S58–S67.

DeWals P, Deceuninck G, Boulianne N, DeSerres G. Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine. JAMA 2004;292(20):2491–94.

Bettinger J, Scheifele D, LeSaux M, Halperin S, Vaudry W, Tsang R. The influence of meningococcal serogroup C conjugate vaccine in Canada. Pediatr Infect Dis J 2008;28(3):220–24.

Siu T, Wrency T, Dawar M, Patrick D. The impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia. Can J Public Health 2008;99(5):380–82.

Kinlin LM, Jamieson F, Brown E, Brown S, Rawte P, Dolman S, et al. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000–2006. Vaccine 2009;27:1735–40.

Stephens DS. Conquering the meningococcus. FEMS Microbiol Rev 2007;31(1):3–14.

British Columbia Centre for Disease Control. Two-year olds; grade six students; grade 12 students with up-to-date immunizations. Vancouver, BC: British Columbia Centre for Disease Control, 2008. Available at: https://doi.org/www.bccdc.org (Accessed September 2008).

Statistics Canada. Age and sex, 2006 counts for both sexes, for Canada, provinces and territories - 100% data. Ottawa, ON: Statistics Canada, 2007.

Keelan J, Lazar H, Wilson K. The national immunization strategy: A model for resolving jurisdictional disputes in public health. Can J Public Health 2008;99(5):376–79.

Borrow R, Miller E. Long-term protection in children with meningococcal C conjugate vaccination: Lessons learned. Expert Rev Vaccines 2006;5(6):851–57.

DeWals P, Coudeville L, Trottier P, Chevat C, Erickson LJ, Nguyen V. Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis. Vaccine 2007;25(29):5433–40.

Trotter CL, Gay NJ, Edmunds WJ. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol 2005;162:89–100.